Phase II study of TAS-114 in combination with S-1 in patients with advanced gastric cancer refractory to prior chemotherpy.
Phase of Trial: Phase II
Latest Information Update: 07 Dec 2017
At a glance
- Drugs TAS 114 (Primary) ; Gimeracil/oteracil/tegafur
- Indications Adenocarcinoma; Gastric cancer
- Focus Therapeutic Use
- Acronyms TAS114_GC study
- 05 Dec 2017 Status changed from not yet recruiting to recruiting.
- 15 Sep 2017 New trial record